Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 2012
[Marked improvement of anemia during treatment with deferasirox in patients with primary myelofibrosis and acute myeloid leukemia with myelodysplasia-related changes]Eri Matsuki, Kimihiro Matsumoto, Aya Nakaya, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2022
[Fecal metabolomic profiles in experimental murine bone marrow transplantation]Erika Sekiguchi, Tomomi Toubai, Masahiro Suto, et al.Psycho-Oncology|February 7, 2025
Unmet Needs and Health-Related Quality of Life Among Patients With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: A Mixed-Methods StudyMiki Sugimoto, Kaori Yagasaki, Eri Matsuki, et al.Biological & Pharmaceutical Bulletin|June 2, 2017
An Empirical Study of the Prescription Pattern of Drugs for Hematological Malignancies in Japan from 2010-2014Shoyo Shibata, Yusuke Wayama, Ai Tsuyuki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
Identification of loss of p16 expression and upregulation of MDR-1 as genetic events resulting from two novel chromosomal translocations found in a plasmablastic lymphoma of the uterusEri Matsuki, Yoshitaka Miyakawa, Shuichi Asakawa, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|August 15, 2018
Lymphocyte-to-Monocyte Ratio May Serve as a Better Prognostic Indicator Than Tumor-associated Macrophages in DLBCL Treated With RituximabEri Matsuki, Olga L Bohn, Siraj El Jamal, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 14, 2012
[Recurrent cellulitis due to Helicobacter cinaedi after chemotherapy for malignant lymphoma]Jo Ishizawa, Takehiko Mori, Yuiko Tsukada, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 5, 2026
Sequential anaphylaxis and delayed rituximab-induced serum sickness with skin testing findings: a case reportShiori Mori, Utako Okata-Karigane, Masaki Arai, et al.International Journal of Hematology|July 19, 2015
Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitorsMasatoshi Sakurai, Takehiko Mori, Daiki Karigane, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 16, 2014
Questionnaire survey on current status of home care and support for patients with hematological diseasesAkiko Adachi, Yuiko Tsukada, Sakiko Kondo, et al.Pageof 4